Vontobel Holding Ltd. Decreases Stock Holdings in DaVita Inc. $DVA

Vontobel Holding Ltd. trimmed its position in shares of DaVita Inc. (NYSE:DVA) by 26.8% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,804 shares of the company’s stock after selling 660 shares during the period. Vontobel Holding Ltd.’s holdings in DaVita were worth $257,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also modified their holdings of the company. National Pension Service raised its holdings in shares of DaVita by 74.3% during the 1st quarter. National Pension Service now owns 197 shares of the company’s stock worth $30,000 after acquiring an additional 84 shares in the last quarter. Y.D. More Investments Ltd purchased a new stake in shares of DaVita during the 1st quarter worth approximately $35,000. Ameritas Advisory Services LLC purchased a new stake in shares of DaVita during the 2nd quarter worth approximately $47,000. NewEdge Advisors LLC raised its holdings in DaVita by 20.8% during the 1st quarter. NewEdge Advisors LLC now owns 511 shares of the company’s stock valued at $78,000 after buying an additional 88 shares during the period. Finally, University of Texas Texas AM Investment Management Co. purchased a new stake in DaVita during the 1st quarter valued at $83,000. 90.12% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, insider James O. Hearty sold 2,351 shares of the stock in a transaction on Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total transaction of $352,650.00. Following the transaction, the insider owned 26,038 shares of the company’s stock, valued at approximately $3,905,700. This represents a 8.28% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.50% of the company’s stock.

DaVita Stock Down 0.6%

DVA stock opened at $125.92 on Thursday. The business’s fifty day simple moving average is $132.61 and its two-hundred day simple moving average is $138.79. DaVita Inc. has a twelve month low of $122.93 and a twelve month high of $179.60. The firm has a market cap of $9.00 billion, a price-to-earnings ratio of 12.38, a PEG ratio of 0.91 and a beta of 1.13.

DaVita (NYSE:DVA) last released its earnings results on Tuesday, August 5th. The company reported $2.95 earnings per share for the quarter, topping analysts’ consensus estimates of $2.70 by $0.25. DaVita had a return on equity of 369.39% and a net margin of 6.35%.The business had revenue of $3.38 billion for the quarter, compared to analyst estimates of $3.36 billion. During the same quarter last year, the firm posted $2.00 earnings per share. The business’s revenue was up 6.1% compared to the same quarter last year. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. Research analysts expect that DaVita Inc. will post 10.76 EPS for the current year.

Analysts Set New Price Targets

Several research firms recently weighed in on DVA. Truist Financial set a $140.00 price target on DaVita in a report on Tuesday. Wall Street Zen lowered DaVita from a “buy” rating to a “hold” rating in a report on Saturday, October 11th. Bank of America decreased their price target on DaVita from $145.00 to $140.00 and set an “underperform” rating on the stock in a report on Wednesday, September 10th. Barclays decreased their price target on DaVita from $160.00 to $149.00 and set an “equal weight” rating on the stock in a report on Thursday, October 9th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of DaVita in a report on Wednesday, October 8th. Four research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, DaVita has a consensus rating of “Reduce” and a consensus price target of $153.25.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.